As of 02 May 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of ticagrelor [90mg film-coated tablet] as an add-on to aspirin for adults with acute coronary syndrome (ACS) for possible financing by the Department of Health (DOH) and/or the Philippine Health Insurance Corporation (PhilHealth). The HTA Council continue reading : HTA Council Preliminary Recommendation on ticagrelor [90mg film-coated tablet] as an add-on to aspirin for adults with acute coronary syndrome (ACS)
HTA Council Preliminary Recommendation on Tetanus, Diptheria, and Acellular Pertussis (Tdap) Vaccine as booster immunization against tetanus, diptheria, and pertussis for Grade 1 students (6-7 years old, Grade 7 students (11-12 years old) and pregnant women
As of 02 May 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccine as booster immunization against tetanus, diphtheria, and pertussis for Grade 1 students (6-7 years old), Grade 7 students (11-12 years old) and pregnant women for possible government financing. continue reading : HTA Council Preliminary Recommendation on Tetanus, Diptheria, and Acellular Pertussis (Tdap) Vaccine as booster immunization against tetanus, diptheria, and pertussis for Grade 1 students (6-7 years old, Grade 7 students (11-12 years old) and pregnant women
HTA Council Preliminary Recommendation on Ceftaroline Fosamil (600 mg powder for concentrate for solution for injection) in the Treatment of Community-Acquired Pneumonia (CAP) in Children
Update as of 14 May 2025 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Ceftaroline Fosamil (600 mg powder for concentrate for solution for injection) in the Treatment of Community-Acquired Pneumonia (CAP) in Children ended on 13 May 2025 without any appeals received, this preliminary HTA Council recommendation lapsed into the Final continue reading : HTA Council Preliminary Recommendation on Ceftaroline Fosamil (600 mg powder for concentrate for solution for injection) in the Treatment of Community-Acquired Pneumonia (CAP) in Children
HTA Council Preliminary Recommendation on Coagulation Factor VIII and Factor VIII Inhibitor Bypassing Activity
Update as of 29 April 2025 : Since the public consultation and appeals period for the HTA Council Preliminary Recommendation on Coagulation Factor VIII and Factor VIII Inhibitor Bypassing Activity ended on 25 April 2025 without any appeals received, this preliminary HTA Council recommendation lapsed into the Final Recommendation and was transmitted to the Secretary of Health on 29 April continue reading : HTA Council Preliminary Recommendation on Coagulation Factor VIII and Factor VIII Inhibitor Bypassing Activity
HTA Council Preliminary Recommendation on Hexavalent Vaccine for active immunization of infants to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis b, and invasive disease due to Haemophilus influenzae type b
As of 05 March 2025, the Health Technology Assessment (HTA) Council makes public its preliminary recommendation on the non-inclusion in the PNF and thus the non-government financing of hexavalent vaccine, for stakeholder feedback/comments. Overall, the HTA Council recognizes that hexavalent vaccines will result in a simpler immunization schedule and thus, better compliance and easier implementation. continue reading : HTA Council Preliminary Recommendation on Hexavalent Vaccine for active immunization of infants to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis b, and invasive disease due to Haemophilus influenzae type b